The Usefulness of Fecal Calprotectin in the era of the COVID-19 Pandemic

ACG Clinical Guideline: Management of Crohn's Disease in Adults

Gary R. Lichtenstein, Edward V. Loftus, Kim L. Isaacs et al. · The American Journal of Gastroenterology · 2018 · 1.4K citations

Medicine, Clinical Sciences, Internal Medicine +12

Prevalence of Inflammatory Bowel Disease Among Adults Aged ≥18 Years — United States, 2015

James M. Dahlhamer, Emily P. Zammitti, Brian Ward et al. · MMWR Morbidity and Mortality Weekly Report · 2016 · 626 citations · Full text

Medicine, Internal Medicine, Epidemiologic Methods +10

Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn’s disease

Francesco Costa · Gut · 2005 · 554 citations · Full text

Veterinary Medicine, Immunology, Gastroenterology +13

Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohnʼs Disease

Eran Zittan, Orlaith Kelly, Richard Kirsch et al. · Inflammatory Bowel Diseases · 2016 · 166 citations

Medicine, Clinical Sciences, Pathology +17

Monitoring inflammatory bowel disease activity: Clinical activity is judged to be more relevant than endoscopic severity or biomarkers

Alain Schoepfer, Stephan R. Vavricka, Nadine Zahnd‐Straumann et al. · Journal of Crohn s and Colitis · 2011 · 63 citations

Medicine, Clinical Sciences, Internal Medicine +13